tiprankstipranks
Advertisement
Advertisement

PCLYFEG Stock Latest News

Lyfegen – Weekly Recap
Private CompaniesLyfegen – Weekly Recap
1d ago
LYFEG
Lyfegen Highlights Opportunity in Product Listing Agreement Infrastructure
PremiumPrivate Companies
Lyfegen Highlights Opportunity in Product Listing Agreement Infrastructure
6d ago
LYFEG
Lyfegen Positions PLA Platform Amid Rising Complexity in Canadian Drug Access
PremiumPrivate Companies
Lyfegen Positions PLA Platform Amid Rising Complexity in Canadian Drug Access
6d ago
LYFEG
Lyfegen Highlights MFN Pricing Risks and Rising Demand for Advanced Drug Contracting Analytics
PremiumPrivate Companies
Lyfegen Highlights MFN Pricing Risks and Rising Demand for Advanced Drug Contracting Analytics
8d ago
LYFEG
MFN Pricing Dynamics Highlight Rising Complexity in Global Drug Launches
PremiumPrivate Companies
MFN Pricing Dynamics Highlight Rising Complexity in Global Drug Launches
13d ago
LYFEG
MFN Pricing Pressures Spotlight Demand for Advanced Drug Contracting Analytics
PremiumPrivate CompaniesMFN Pricing Pressures Spotlight Demand for Advanced Drug Contracting Analytics
13d ago
LYFEG
Lyfegen Targets Digital PLA Management Opportunities in Canadian Payer Market
Premium
Private Companies
Lyfegen Targets Digital PLA Management Opportunities in Canadian Payer Market
17d ago
LYFEG
Lyfegen Targets Growing Demand for Digital PLA Management in Canadian Healthcare
Premium
Private Companies
Lyfegen Targets Growing Demand for Digital PLA Management in Canadian Healthcare
17d ago
LYFEG
Lyfegen Positions Around Rising Complexity in Global Drug Pricing and Contracting
PremiumPrivate Companies
Lyfegen Positions Around Rising Complexity in Global Drug Pricing and Contracting
20d ago
LYFEG
Lyfegen Highlights Rising Complexity in Global Drug Pricing and Contracting
PremiumPrivate Companies
Lyfegen Highlights Rising Complexity in Global Drug Pricing and Contracting
20d ago
LYFEG
Lyfegen – Weekly Recap
PremiumPrivate Companies
Lyfegen – Weekly Recap
22d ago
LYFEG
Lyfegen Targets PLA Management Opportunities at Canada’s Drug Agency Symposium
PremiumPrivate Companies
Lyfegen Targets PLA Management Opportunities at Canada’s Drug Agency Symposium
24d ago
LYFEG
Lyfegen Targets Canadian Market Access Stakeholders at National Drug Agency Symposium
PremiumPrivate CompaniesLyfegen Targets Canadian Market Access Stakeholders at National Drug Agency Symposium
24d ago
LYFEG
Lyfegen Sharpens Focus on MFN Drug Pricing and Market Access Ahead of 2026 Basel Forums
Premium
Private Companies
Lyfegen Sharpens Focus on MFN Drug Pricing and Market Access Ahead of 2026 Basel Forums
29d ago
LYFEG
Lyfegen Targets Market Access Visibility at 2026 Basel Pricing and Payer Forums
Premium
Private Companies
Lyfegen Targets Market Access Visibility at 2026 Basel Pricing and Payer Forums
1M ago
LYFEG
Lyfegen Highlights MFN Drug Pricing Impact on Global Launch Strategies
PremiumPrivate Companies
Lyfegen Highlights MFN Drug Pricing Impact on Global Launch Strategies
1M ago
LYFEG
Lyfegen Examines MFN Drug Pricing Impact on Global Launch and Access Strategies
PremiumPrivate Companies
Lyfegen Examines MFN Drug Pricing Impact on Global Launch and Access Strategies
1M ago
LYFEG
MFN Drug Pricing Pressures Disrupt Global Launch Strategies and Patient Access
PremiumPrivate Companies
MFN Drug Pricing Pressures Disrupt Global Launch Strategies and Patient Access
1M ago
LYFEG
MFN Drug Pricing Pressures Highlighted as Launch Delays and Market Exits Mount
PremiumPrivate Companies
MFN Drug Pricing Pressures Highlighted as Launch Delays and Market Exits Mount
1M ago
LYFEG
Lyfegen Targets Pharma Contracting as Strategic Market Access Opportunity
PremiumPrivate CompaniesLyfegen Targets Pharma Contracting as Strategic Market Access Opportunity
1M ago
LYFEG
Lyfegen Targets Strategic Pharma Contracting and Market Access
Premium
Private Companies
Lyfegen Targets Strategic Pharma Contracting and Market Access
1M ago
LYFEG
Lyfegen Invests in Product Design to Support Complex Drug Contracting Platform
Premium
Private Companies
Lyfegen Invests in Product Design to Support Complex Drug Contracting Platform
1M ago
LYFEG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >